Streetbeat News

TIVC

Tivic Health Systems, Inc.

https://www.tivichealth.com

Industry

Medical - Devices

Tivic Health Systems Inc. operates as a bioelectronic device company that delivers non-invasive neuromodulation products for the treatment of inflammatory conditions. Its primary product is ClearUP, is a medical device intended to relieve sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, including BestBuy.com and FSAStore.com. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.

Open

0.30

Mkt cap

1.8M

Volume

2.2M

High

0.31

P/E Ratio

0.02

52-wk high

3.21

Low

0.25

Div yield

N/A

52-wk low

0.22

Tivic Health Systems, Inc. (NASDAQ:TIVC) has been issued its sixth patent for its bioelectronic platform by the U.S. Patent and Trademark Office. The patent expands the company's intellectual property to include proprietary contacts, conductive circuitry design, and algorithms to optimize therapy delivery. The company has an additional 17 patents pending in the U.S. and abroad.

Portfolio Pulse from Happy Mohamed

July 31, 2023 | 1:12 pm

Several healthcare stocks experienced significant movement in Wednesday's after-market session. Gainers included Dynatronics (DYNT), Novan (NOVN), Trinity Biotech (TRIB), 9 Meters Biopharma (NMTR), Tivic Health Systems (TIVC), and Oncternal Therapeutics (ONCT). Losers included Healthcare Triangle (HCTI), EUDA Health Holdings (EUDA), Enochian BioSciences (ENOB), Biodexa Pharmaceuticals (BDRX), Trevena (TRVN), and Evelo Biosciences (EVLO).

Portfolio Pulse from Benzinga Insights

July 19, 2023 | 9:32 pm

During Monday's intraday session, several healthcare stocks experienced significant movements. BridgeBio Pharma, Acumen Pharmaceuticals, Quantum-Si, Lixte Biotech Hldgs, argenx, and Rockwell Medical saw their shares rise by 78.8%, 62.89%, 33.91%, 28.91%, 27.33%, and 24.29% respectively. On the other hand, ViewRay, Novan, Tivic Health Systems, Virios Therapeutics, Apellis Pharmaceuticals, and Minerva Surgical saw their shares fall by 78.5%, 69.64%, 29.31%, 22.94%, 21.72%, and 17.3% respectively.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 5:31 pm

Several stocks experienced significant movement in Monday's mid-day session. ProMIS Neurosciences, Acumen Pharmaceuticals, BridgeBio Pharma, Lixte Biotechnology Holdings, and Healthcare Triangle were among the top gainers, with shares jumping due to various reasons such as positive preclinical data, successful Phase 1 studies, and strong financial results. On the other hand, Novan, ViewRay, UTime Limited, Jiuzi Holdings, and BYND Cannasoft Enterprises were among the biggest losers, with shares falling due to factors such as asset sales, Chapter 11 filings, and direct offerings.

Portfolio Pulse from Lisa Levin

July 17, 2023 | 5:14 pm

On Monday, 50 companies reached new 52-week lows. The biggest company by market cap to set a new 52-week low was Verizon Communications (NYSE:VZ), while the smallest was Galmed Pharmaceuticals (NASDAQ:GLMD). Novan (NASDAQ:NOVN) was the biggest loser of the morning session, dropping 72.16% to reach its new 52-week low. Cal-Maine Foods (NASDAQ:CALM) shares were the most resilient, rising 0.06% from its new 52-week low.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 4:17 pm

During Monday's pre-market session, several healthcare stocks experienced significant movements. Acumen Pharmaceuticals, BridgeBio Pharma, Healthcare Triangle, argenx, Lixte Biotech Hldgs, and Travere Therapeutics saw increases in their share prices, while ViewRay, Tivic Health Systems, Apellis Pharmaceuticals, Minerva Surgical, Frequency Therapeutics, and Virios Therapeutics experienced decreases.

Portfolio Pulse from Benzinga Insights

July 17, 2023 | 1:06 pm

Tivic Health Systems has announced the pricing of a $2.1 million public offering of common stock, leading to a decrease in its share price.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:36 pm

Tivic Health has announced the pricing of its public offering of 51,250,000 shares of common stock at $0.04 per share, raising $2.1 million.

Portfolio Pulse from Benzinga Newsdesk

July 17, 2023 | 12:32 pm

Tivic Health Systems, Inc. (NASDAQ:TIVC) has announced its intention to offer and sell shares of its common stock in a public offering. The proceeds from the offering will be used for working capital and general corporate purposes. The completion of the offering is subject to market and other conditions. Maxim Group LLC is acting as the sole placement agent for the offering.

Portfolio Pulse from Happy Mohamed

July 14, 2023 | 8:04 pm

US stocks traded higher with the Nasdaq Composite slightly up. Mobilicom Limited (NASDAQ:MOB) shares rose 85% after receiving a commercial scale purchase order from Teledyne-FLIR for drone production for the US Department of Defense. Jupiter Wellness, Inc. (NASDAQ:JUPW) shares rose 42% after announcing an Asset Purchase Agreement with GBB Drink Lab. NanoString Technologies, Inc. (NASDAQ:NSTG) shares rose 37% after the company raised its Q2 revenue guidance. Tivic Health Systems, Inc. (NASDAQ:TIVC) shares dropped 37% after pricing a public offering of 32.5 million shares. The Aaron's Company, Inc. (NYSE:AAN) shares fell 11% after Loop Capital downgraded the stock. FMC Corporation (NYSE:FMC) shares fell 11% after the company cut its Q2 and 2023 guidance.

Portfolio Pulse from Lisa Levin

July 10, 2023 | 6:43 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.